AEON Biopharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- AEON Biopharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AEON
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001837607
Board of directors
-
Eric G. Carter · DirectorSince 2023
-
Jost Fischer · DirectorSince 2023
-
Marc Forth · Director · CHIEF EXECTUIVE OFFICERSince 2023
-
Robert E. Bancroft · Director · PRESIDENT & CEOSince 2025
-
Robert J. Palmisano · DirectorSince 2023
-
Seongsoo Park · DirectorSince 2024
-
Shelley B. Thunen · DirectorSince 2023
Chief executives
Robert E. Bancroft
· President & CEO
Since April 2025
Board connections
2 of this board's directors also sit on 2 other boards.
- via Shelley B. Thunen
- via Robert J. Palmisano
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $243,455
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | LYNCH TIMOTHY P 10% owner | Open-market purchase | +1,150,000 | $0.21 | $243,455 |
| Jun 17, 2026 | Shelley B. Thunen Director | Grant or award | +222,684 | — | — |
| Jun 17, 2026 | Robert J. Palmisano Director | Grant or award | +222,684 | — | — |
| Jun 17, 2026 | Marc Forth Director | Grant or award | +222,684 | — | — |
| Jun 17, 2026 | Jost Fischer Director | Grant or award | +222,684 | — | — |
| Jun 17, 2026 | Eric G. Carter Director | Grant or award | +222,684 | — | — |
| Apr 2, 2026 | John Bencich Officer (CHIEF FINANCIAL OFFICER) | Grant or award | +754,717 | — | — |
| Mar 4, 2026 | Oh Chad Officer (CHIEF MEDICAL OFFICER) | Grant or award | +1,316,872 | — | — |
| Mar 4, 2026 | Wilson Alexander Blair Officer (CLO, CSO, and Corp Secretary) | Grant or award | +1,316,872 | — | — |
| Mar 4, 2026 | Sy Jennifer Officer (PRINCIPAL ACCOUNTING OFFICER) | Grant or award | +925,925 | — | — |
| Feb 17, 2026 | Oh Chad Officer (CHIEF MEDICAL OFFICER) | Grant or award | +862,500 | — | — |
| Feb 17, 2026 | Wilson Alexander Blair Officer (CLO, CSO, and Corp Secretary) | Grant or award | +862,500 | — | — |
| Feb 17, 2026 | Sy Jennifer Officer (PRINCIPAL ACCOUNTING OFFICER) | Grant or award | +575,000 | — | — |
| Feb 17, 2026 | Robert E. Bancroft Director, Officer (PRESIDENT & CEO) | Grant or award | +3,000,000 | — | — |
| May 21, 2025 | Jost Fischer Director | Open-market purchase | +60,000 | $0.49 | $29,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.